Clinical trial testing efficacy of antibody against SARS-CoV-2 begins
The University of Chicago Medicine is launching a clinical trial to examine the potential of an antibody against the SARS-CoV-2 spike protein for treating COVID-19, the disease caused by the novel coronavirus.
Sep 3, 2020
0
7